Fundraising FoxAccelerate Diagnostics
Tucson, US · Delaware corporation
Find your way into Accelerate Diagnostics
Sign up to see every warm intro you have to Accelerate Diagnostics
- Paths you didn't know you had: your email and LinkedIn already hold routes to the Accelerate Diagnostics team. We find them for you
- 2nd- and 3rd-degree connections: the friend-of-a-friend routes that take hours to manually find through your inbox or LinkedIn
- Answers now, not in days: momentum is everything in a raise. Skip asking around whether someone knows someone
Days of research, done the moment you sign in, with every route ranked by how warm it is.
Founders & leadership
FJ
Frank J.M. ten BrinkNamed on SEC filing
TD
Thomas D. BrownNamed on SEC filing
MC
Mark C. MillerNamed on SEC filing
CW
Charles WattsNamed on SEC filing
RP
Ron PriceNamed on SEC filing
HM
Hany MassaranyNamed on SEC filing
JJ
John J. PhillipsNamed on SEC filing
SR
Steve ReichlingNamed on SEC filing
Board
MW
Matthew W. StrobeckBoard director
JP
John PatienceBoard director
Reported raises · per SEC filings
Form D private placements$56.5M disclosed across 5 rounds · 2014–2022
▶$4MraisedApr 2022 · 3 investors · BiotechnologyRule 506(b)
▶$4MraisedApr 2022 · 3 investors · Biotechnology
Rule 506(b)Officers, directors & promoters on the filing
- John PatienceDirector
- Hany MassaranyDirector
- Charles WattsDirector
- Mark C. MillerDirector
- Frank J.M. ten BrinkDirector
- Louise L. FrancesconiDirector
- Jack SchulerDirector
- John J. PhillipsExecutive Officer, Director
- Ron PriceExecutive Officer
- Steve ReichlingExecutive Officer
- Thomas D. BrownDirector
- Wayne C. BurrisDirector
- Matthew W. StrobeckDirector
- Offering amount
- $4M
- Amount sold
- $4M
- First sale
- Mar 2022
- Incorporated
- Corporation, Delaware
- Federal exemptions
- 06b
▶$1.6MraisedSep 2021 · 5 investors · BiotechnologyRule 506(b)
▶$1.6MraisedSep 2021 · 5 investors · Biotechnology
Rule 506(b)Officers, directors & promoters on the filing
- Louise L. FrancesconiDirector
- Matthew W. StrobeckDirector
- John PatienceDirector
- Frank J.M. ten BrinkDirector
- Thomas D. BrownDirector
- Mark C. MillerDirector
- Charles WattsDirector
- Ron PriceExecutive Officer
- Hany MassaranyDirector
- Jack SchulerDirector
- John J. PhillipsExecutive Officer, Director
- Steve ReichlingExecutive Officer
- Offering amount
- $1.6M
- Amount sold
- $1.6M
- First sale
- Dec 2020
- Incorporated
- Corporation, Delaware
- Federal exemptions
- 06b
▶$30.4MraisedSep 2021 · 3 investors · BiotechnologyRule 506(b)
▶$30.4MraisedSep 2021 · 3 investors · Biotechnology
Rule 506(b)Officers, directors & promoters on the filing
- Ron PriceExecutive Officer
- Matthew W. StrobeckDirector
- Thomas D. BrownDirector
- John PatienceDirector
- John J. PhillipsExecutive Officer, Director
- Mark C. MillerDirector
- Jack SchulerDirector
- Louise L. FrancesconiDirector
- Hany MassaranyDirector
- Frank J.M. ten BrinkDirector
- Steve ReichlingExecutive Officer
- Charles WattsDirector
- Offering amount
- $30.4M
- Amount sold
- $30.4M
- First sale
- Sep 2021
- Incorporated
- Corporation, Delaware
- Federal exemptions
- 06b
▶$1000KraisedAug 2019 · 1 investors · BiotechnologyRule 506(b)
▶$1000KraisedAug 2019 · 1 investors · Biotechnology
Rule 506(b)Officers, directors & promoters on the filing
- Charles WattsDirector
- Jack SchulerDirector
- Ron PriceExecutive Officer
- John J. PhillipsExecutive Officer
- Frank J.M. ten BrinkDirector
- Matthew W. StrobeckDirector
- Romney HumphriesExecutive Officer
- John PatienceDirector
- Mark C. MillerDirector
- Lawrence MehrenExecutive Officer, Director
- Thomas D. BrownDirector
- Steve ReichlingExecutive Officer
- Offering amount
- $1000K
- Amount sold
- $1000K
- First sale
- Aug 2019
- Incorporated
- Corporation, Delaware
- Federal exemptions
- 06b
▶$19.5MraisedJun 2014 · 4 investors · BiotechnologyRule 506(b)
▶$19.5MraisedJun 2014 · 4 investors · Biotechnology
Rule 506(b)Officers, directors & promoters on the filing
- Steve ReichlingExecutive Officer
- John PatienceDirector
- Lawrence MehrenExecutive Officer, Director
- Pete BantockExecutive Officer
- Matthew W. Strobeck, Ph.DDirector
- Mark C. MillerDirector
- Jack SchulerDirector
- Frank J.M. ten BrinkDirector
- Offering amount
- $19.5M
- Amount sold
- $19.5M
- First sale
- May 2014
- Incorporated
- Corporation, Delaware
- Federal exemptions
- 06b
Source: SEC EDGAR Form D. Amounts as filed; amended filings shown once at their latest values.
Frequently asked questions
- How much funding has Accelerate Diagnostics raised?
- Accelerate Diagnostics has disclosed $56.5M raised across 5 rounds.
- Where is Accelerate Diagnostics headquartered?
- Accelerate Diagnostics is headquartered in Tucson, US.